Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001493152-25-023624
Filing Date
2025-11-14
Accepted
2025-11-14 17:04:05
Documents
1
Period of Report
2025-09-30
Effectiveness Date
2025-11-14

Document Format Files

Seq Description Document Type Size
1 NT 10-Q formnt10-q.htm NT 10-Q 32892
  Complete submission text file 0001493152-25-023624.txt   34266
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0331
Type: NT 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 251487994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)